VIDEO: Expert discusses positives, negatives from virtual SABCS meeting, RxPonder data
The virtual format of this year’s San Antonio Breast Cancer Symposium had its negatives, like missing discussions with colleagues, and its positives, according to Elias Obeid, MD, MPH.
“One of the positives is that there weren’t that many side meetings and that gave me the time to attend most of the sessions this year,” he said.
Obeid, interim chief of the division of breast medical oncology and director of the Breast, Ovarian, and Prostate Cancer Risk Assessment Program at Fox Chase Cancer Center and assistant professor in the department of genetics at Temple University, also briefly described findings from the RxPonder study and touched on data from the monarchE and PENELOPE-B trials, which both investigated CDK4/6 inhibitors.
Collapse
Kalinsky K. Abstract GS3-00. Presented at: San Antonio Breast Cancer Symposium (Virtual); Dec. 8-11, 2020.
Loibl S. Abstract GS1-02. Presented at: San Antonio Breast Cancer Symposium (Virtual); Dec. 8-11, 2020.
O'Shaughnessy JA. Abstract GS1-01. Presented at: San Antonio Breast Cancer Symposium (Virtual); Dec. 8-11, 2020
Read more about